Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16609157rdf:typepubmed:Citationlld:pubmed
pubmed-article:16609157lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:16609157lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16609157lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:16609157lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:16609157lifeskim:mentionsumls-concept:C0027778lld:lifeskim
pubmed-article:16609157pubmed:issue4lld:pubmed
pubmed-article:16609157pubmed:dateCreated2006-4-12lld:pubmed
pubmed-article:16609157pubmed:abstractTextThe prevalence of the genotypes of the hepatitis C virus (HCV) differs according to geographical location. In the United States and in European countries, the majority of patients are infected with genotype 1, 2 or 3. There is a lack of data on the distribution of HCV genotypes in The Netherlands.lld:pubmed
pubmed-article:16609157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16609157pubmed:languageenglld:pubmed
pubmed-article:16609157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16609157pubmed:citationSubsetIMlld:pubmed
pubmed-article:16609157pubmed:statusMEDLINElld:pubmed
pubmed-article:16609157pubmed:monthAprlld:pubmed
pubmed-article:16609157pubmed:issn0300-2977lld:pubmed
pubmed-article:16609157pubmed:authorpubmed-author:de VriesM JMJlld:pubmed
pubmed-article:16609157pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:16609157pubmed:authorpubmed-author:te RijdtBBlld:pubmed
pubmed-article:16609157pubmed:issnTypePrintlld:pubmed
pubmed-article:16609157pubmed:volume64lld:pubmed
pubmed-article:16609157pubmed:ownerNLMlld:pubmed
pubmed-article:16609157pubmed:authorsCompleteYlld:pubmed
pubmed-article:16609157pubmed:pagination109-13lld:pubmed
pubmed-article:16609157pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:meshHeadingpubmed-meshheading:16609157...lld:pubmed
pubmed-article:16609157pubmed:year2006lld:pubmed
pubmed-article:16609157pubmed:articleTitleGenotype distribution amongst hepatitis C patients in The Netherlands.lld:pubmed
pubmed-article:16609157pubmed:affiliationRoche Nederland BV, Woerden, The Netherlands. martin.de_vries@roche.comlld:pubmed
pubmed-article:16609157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16609157pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16609157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16609157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16609157lld:pubmed